BioNTech SE (BNTX) Non-Current Debt (2018 - 2024)

BioNTech SE has disclosed Non-Current Debt across 7 years of filings, most recently posting $50.1 million for Q4 2024.

• Non-Current Debt for Q4 2024 came in at $50.1 million, up 20.05% year-over-year; the trailing twelve-month figure through Dec 2024 was $50.1 million (up 20.05% YoY), and the FY2024 annual result was $50.1 million, up 20.05% from the prior year.
• Non-Current Debt came in at $50.1 million for Q4 2024 at BioNTech SE, up from $41.7 million in the prior quarter.
• In the past five years, Non-Current Debt ranged from a high of $275.4 million in Q4 2020 to a low of $6.2 million in Q4 2022.
• The 5-year median for Non-Current Debt is $50.1 million (2024), against an average of $115.4 million.
• Across the five-year window, Non-Current Debt plunged 96.94% in 2022 and jumped 570.79% in 2023, its largest moves.
• BioNTech SE's Non-Current Debt stood at $275.4 million in 2020, then fell by 26.19% to $203.3 million in 2021, then slumped by 96.94% to $6.2 million in 2022, then surged by 570.79% to $41.7 million in 2023, then advanced by 20.05% to $50.1 million in 2024.
• The last three Non-Current Debt figures came in at $50.1 million (Q4 2024), $41.7 million (Q4 2023), and $6.2 million (Q4 2022), per Business Quant data.